Polyclonal Rabbit anti‑Human Osteocalcin Antibody (C‑Terminus, IHC) LS‑C328106
Polyclonal Rabbit anti‑Human Osteocalcin Antibody (C‑Terminus, IHC) LS‑C328106
Antibody:
Osteocalcin Rabbit anti-Human Polyclonal (C-Terminus) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
Osteocalcin Rabbit anti-Human Polyclonal (C-Terminus) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
Osteocalcin antibody LS-C328106 is an unconjugated rabbit polyclonal antibody to human Osteocalcin (C-Terminus). Validated for ELISA and IHC.
Target
Human Osteocalcin
Synonyms
BGLAP | Bone Gla protein | BGP | OC | Osteocalcin
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated.
Also available conjugated with
APC,
FITC,
Biotin,
HRP,
PE.
Purification
Affinity purified
Modifications
Unmodified.
Also available
Azide-free.
Immunogen
KLH conjugated synthetic peptide selected from the C-Terminus of human osteocalcin.
Applications
- IHC (1:50 - 1:100)
- ELISA (1:1000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 0.09% Sodium Azide
Storage
May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for up to 1 year.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
Immunofluorescence, Western blot, ELISA
Species:
Human
Applications:
ICC, ELISA
Species:
Mouse
Applications:
Western blot
Species:
Human
Applications:
ELISA
Species:
Human
Applications:
ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/3/2024